A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Dexmedetomidine Hydrochloride In (Dexmedetomidine Hydrochloride)

Central alpha-2 Adrenergic Agonist class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2019-08-27
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Dexmedetomidine Hydrochloride In used for?

Dexmedetomidine Hydrochloride In is a Central alpha-2 Adrenergic Agonist medication tracked in Medicare Part D.

Is there a generic for Dexmedetomidine Hydrochloride In?

No. Dexmedetomidine Hydrochloride In is brand-only with no generic equivalents currently in market.

How much does my plan pay for Dexmedetomidine Hydrochloride In?

NADAC pricing data not currently available for this drug.

Is Dexmedetomidine Hydrochloride In on the FDA shortage list?

No. Dexmedetomidine Hydrochloride In is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Central alpha-2 Adrenergic Agonist4 alternatives in D1
01
Clonidine
Brand: Duraclon
$0.025Lowest NADAC
23Generic mfrs
$123.7MCY24 Part D spend
Compare →
02
Clonidine Transdermal System
Brand: Catapres-TTS-1
$7.23Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Dexmedetomidine
Brand: Dexmedetomidine Hydrochloride in Sodium Chloride
Lowest NADAC
24Generic mfrs
$308,999CY24 Part D spend
Compare →
04
Guanfacine
Brand: GUANFACINE
$0.140Lowest NADAC
18Generic mfrs
$14.4MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.